| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Edgewise Therapeutics, Inc. | Director | Stock Options (Right to buy) | 45,150 | 19 Nov 2025 | Direct | ||
| Oruka Therapeutics, Inc. | Director | Stock Option (right to buy) | 35,000 | 11 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ORKA | Oruka Therapeutics, Inc. | 11 Dec 2025 | 1 | $0 | 4 | Director | 11 Dec 2025, 16:41 |
| ORKA | Oruka Therapeutics, Inc. | 11 Dec 2025 | 0 | $0 | 3 | Director | 11 Dec 2025, 16:32 |
| EWTX | Edgewise Therapeutics, Inc. | 19 Nov 2025 | 1 | $0 | 4 | Director | 24 Nov 2025, 19:08 |
| EWTX | Edgewise Therapeutics, Inc. | 19 Nov 2025 | 0 | $0 | 3 | Director | 24 Nov 2025, 19:06 |